Optex Systems Holdings Inc 10-Q

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 28, 2021 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______to______. OPTEX SYSTEMS HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) Delaware 000-54114 90-0609531 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 1420 Presidential Drive, Richardson, TX 75081-2439 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (972) 764-5700 Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act (Check one): Large Accelerated Filer [ ] Accelerated Filer [ ] Non-Accelerated Filer [X] Smaller Reporting Company [X] [ ] Emerging growth company [ ] If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act. Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [ ] Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Yes [ ] No [X] Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act. Yes [ ] No [X] Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered None. State the number of shares outstanding of each of the issuer’s classes of common equity, as of May 7, 2021: 8,334,995 shares of common stock. OPTEX SYSTEMS HOLDINGS, INC. FORM 10-Q For the period ended March 28, 2021 INDEX PART I— FINANCIAL INFORMATION F-1 Item 1. Consolidated Financial Statements F-1 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 3 Item 4. Control and Procedures 14 PART II— OTHER INFORMATION 15 Item 1 Legal Proceedings 15 Item 1A Risk Factors 15 Item 4 Mine Safety Disclosures 15 Item 6. Exhibits 15 SIGNATURE 16 2 Part 1. Financial Information Item 1. Consolidated Financial Statements OPTEX SYSTEMS HOLDINGS, INC. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 28, 2021 CONDENSED CONSOLIDATED BALANCE SHEETS AS OF MARCH 28, 2021 (UNAUDITED) AND SEPTEMBER 27, 2020 F-2 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED MARCH 28, 2021 (UNAUDITED) AND THE THREE AND SIX MONTHS ENDED MARCH 29, 2020 (UNAUDITED) F-3 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED MARCH 28, 2021 (UNAUDITED) F-4 CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY FOR THE THREE AND SIX MONTHS ENDED MARCH 28, 2021 (UNAUDITED) AND FOR THE THREE AND SIX MONTHS ENDED MARCH 29, 2020 (UNAUDITED) F-5 CONDENSED CONSOLIDATED FINANCIAL STATEMENT FOOTNOTES (UNAUDITED) F-6 F- 1 Optex Systems Holdings, Inc. Condensed Consolidated Balance Sheets (Thousands, except share and per share data) March 28, 2021 (Unaudited) September 27, 2020 ASSETS Cash and Cash Equivalents $ 3,880 $ 4,700 Accounts Receivable, Net 2,031 2,953 Inventory, Net 8,993 8,791 Prepaid Expenses 158 229 Current Assets 15,062 16,673 Property and Equipment, Net 1,005 1,006 Other Assets Deferred Tax Asset 1,195 1,227 Right-of-use Asset 3,842 1,416 Security Deposits 23 23 Other Assets 5,060 2,666 Total Assets $ 21,127 $ 20,345 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities Accounts Payable $ 537 $ 833 Operating Lease Liability 477 417 Accrued Expenses 812 1,077 Warrant Liability 1,686 2,544 Accrued Warranty Costs 63 83 Customer Advance Deposits - 1 Current Liabilities 3,575 4,955 Other Liabilities Credit Facility - Long Term 377 377 Operating Lease Liability, net of current portion 3,374 1,037 Other Liabilities 3,751 1,414 Total Liabilities 7,326 6,369 Commitments and Contingencies Stockholders’ Equity Common Stock – ($0.001 par, 2,000,000,000 authorized, 8,854,261 and 8,795,869 shares issued, and 8,373,594 and 8,690,136 outstanding, respectively) 9 9 Treasury Stock (at cost, 480,667 shares and 105,733 shares held, respectively) (930 ) (200 ) Additional Paid in capital 26,346 26,276 Accumulated Deficit (11,624 ) (12,109 ) Stockholders’ Equity 13,801 13,976 Total Liabilities and Stockholders’ Equity $ 21,127 $ 20,345 The accompanying notes are an integral part of these financial statements F- 2 Optex Systems Holdings, Inc. Condensed Consolidated Statements of Operations (Thousands, except share and per share data) Three months ended Six months ended March 28, 2021 March 29, 2020 March 28, 2021 March 29, 2020 Revenue $ 4,246 $ 6,947 $ 8,717 $ 12,833 Cost of Sales 3,868 5,328 7,504 9,747 Gross Margin 378 1,619 1,213 3,086 General and Administrative Expense 792 838 1,548 1,587 Operating Income (Loss) (414 ) 781 (335 ) 1,499 Gain (Loss) on Change in Fair Value of Warrants (169 ) 1,332 858 81 Interest Expense (2 ) (6 ) (5 ) (11 ) Other Income (Expense) (171 ) 1,326 853 70 Income (Loss) Before Taxes (585 ) 2,107 518 1,569 Income Tax Expense, net $ 17 $ 163 33 304 Net Income (Loss) $ (602 ) $ 1,944 $ 485 $ 1,265 Deemed dividends on participating securities - (633 ) (162 ) (413 ) Net income (loss) applicable to common shareholders $ (602 ) $ 1,311 $ 323 $ 852 Basic income (loss) per share $ (0.07 ) $ 0.15 $ 0.04 $ 0.10 Weighted Average Common Shares Outstanding - basic 8,214,481 8,549,437 8,256,879 8,522,653 Diluted income (loss) per share $ (0.07 ) $ 0.15 $ 0.04 $ 0.10 Weighted Average Common Shares Outstanding - diluted 8,214,481 8,604,446 8,369,763 8,607,460 The accompanying notes are an integral part of these financial statements F- 3 Optex Systems Holdings, Inc. Consolidated Statements of Cash Flows (Thousands) Six months ended March 28, 2021 March 29, 2020 Cash Flows from Operating Activities: Net Income $ 485 $ 1,265 Adjustments to Reconcile Net Income to Net Cash provided by Operating Activities: Depreciation and Amortization 128 125 Gain on Change in Fair Value of Warrants (858 ) (81 ) Stock Compensation Expense 114 57 Deferred Tax 33 111 Accounts Receivable 922 (860 ) Inventory (202 ) 725 Prepaid Expenses 71 191 Leases (29 ) (20 ) Accounts Payable and Accrued Expenses (561 ) (817 ) Accrued Warranty Costs (20 ) 59 Customer Advance Deposits (1 ) (3 ) Total Adjustments (403 ) (513 ) Net Cash provided by Operating Activities 82 752 Cash Flows used in Investing Activities Purchases of Property and Equipment (128 ) (96 ) Net Cash used in Investing Activities (128 ) (96 ) Cash Flows used in Financing Activities Cash Paid for Taxes Withheld On Net Settled Restricted Stock Unit Share Issue (44 ) (54 ) Stock Repurchase (730 ) - Net Cash used in Financing Activities (774 ) (54 ) Net Increase (Decrease) in Cash and Cash Equivalents (820 ) 602 Cash and Cash Equivalents at Beginning of Period 4,700 1,068 Cash and Cash Equivalents at End of Period $ 3,880 $ 1,670 Supplemental Cash Flow Information: Non Cash Transactions: Right-of-Use Asset $ 3,688 $ 1,811 Operating Lease Liabilities (3,688 ) (1,894 ) Cash Transactions: Cash Paid for Taxes 48 152 Cash Paid for Interest 5 11 The accompanying notes are an integral part of these financial statements F- 4 Optex Systems Holdings, Inc. Consolidated Statement of Stockholders’ Equity (Thousands, except share data) Three months ended March 28, 2021 Common Shares Issued Treasury Shares Common Stock Treasury Stock Additional Paid in Capital Retained Earnings Total Stockholders Equity Balance at December 27, 2020 8,795,869 314,325 $ 9 $ (615 ) $ 26,333 $ (11,022 ) $ 14,705 Stock Compensation Expense - - - - 57 - 57 Vested restricted stock units issued net of tax withholding 58,392 - - - (44 ) - (44 ) Common Stock Repurchase (1) - 166,342 - (315 ) - - (315 ) Net loss - - - - - (602 ) (602 ) Balance at March 28, 2021 8,854,261 480,667 $ 9 $ (930 ) $ 26,346 $ (11,624 ) $ 13,801 Six months ended March 28, 2021 Common Shares Issued Treasury Shares Common Stock Treasury Stock Additional Paid in Capital Retained Earnings Total Stockholders Equity Balance at September 27, 2020 8,795,869 105,733 $ 9 $ (200 ) $ 26,276 $ (12,109 ) $ 13,976 Stock Compensation Expense - - - - 114 - 114 Vested restricted stock units issued net of tax withholding 58,392 - - - (44 ) - (44 ) Common Stock Repurchase (1) - 374,934 - (730 ) - - (730 ) Net income - - - - - 485 485 Balance at March 28, 2021 8,854,261 480,667 $ 9 $ (930 ) $ 26,346 $ (11,624 ) $ 13,801 Three months ended March 29, 2020 Common Shares Issued Treasury Shares Common Stock Treasury Stock Additional Paid in Capital Retained Earnings Total Stockholders Equity Balance at December 29, 2019 8,436,422 - $ 8 $ - $ 26,160 $ (14,613 ) 11,555 Stock Compensation Expense - - - 31 - 31 Vested restricted stock units issued net of tax withholding 59,447 - - (54 ) - (54 ) Net income - - - - 1,944 1,944 Balance at March 29, 2020 8,495,869 - $ 8 $ - $ 26,137 $ (12,669 ) $ 13,476 Six months ended March 29, 2020 Common Shares Issued Treasury Shares Common Stock Treasury Stock Additional Paid in Capital Retained Earnings Total Stockholders Equity Balance at September 29, 2019 8,436,422 - $ 8 $ - $ 26,134 $ (13,934 ) 12,208 Stock Compensation Expense - - - 57 - 57 Vested restricted stock units issued net of tax withholding 59,447 - - (54 ) - (54 ) Net income - - - - 1,265 1,265 Balance at March 29, 2020 8,495,869 - $ 8 $ - $ 26,137 $ (12,669 ) $ 13,476 (1) Common shares repurchased in the open market through March 28, 2021 and held in treasury stock using the cost method. The accompanying notes are an integral part of these financial statements F- 5 Note 1 - Organization and Operations Optex Systems Holdings, Inc. (the “Company”) manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications and commercial markets. Its products are installed on a variety of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and advanced security vehicles, and have been selected for installation on the Stryker family of vehicles. The Company also manufactures and delivers numerous periscope configurations, rifle and surveillance sights and night vision optical assemblies. Optex Systems Holdings’ products consist primarily of build to customer print products that are delivered both directly to the military and to other defense prime contractors or commercial customers. The Company’s consolidated revenues are derived from the U.S. government, 25%, three major U.S. defense contractors, 31%, 13% and 9%, one commercial customer 5%, and all other customers, 17%. Approximately 89% of the total company revenue is generated from domestic customers and 11% is derived from foreign customers. Optex Systems Holdings’ operations are based in Dallas and Richardson, Texas in leased facilities comprising 93,967 square feet. As of March 28, 2021, Optex Systems Holdings operated with 85 full-time equivalent employees. We may be at risk as a result of the current COVID-19 pandemic. Risks that could affect our business include the duration and scope of the COVID-19 pandemic and the impact on the demand for our products; actions by governments, businesses and individuals taken in response to the pandemic; the length of time of the COVID-19 pandemic and the possibility of its reoccurrence; the timing required to develop effective treatments and distribute vaccines in the event of future outbreaks; the eventual impact of the pandemic and actions taken in response to the pandemic on global and regional economies; and the pace of recovery when the COVID-19 pandemic subsides. During the last twelve months, we have experienced a significant reduction in new orders and ending customer backlog across all but one of our product lines. We attribute the lower orders to a combination of factors including a COVID-19 driven slow-down of contract awards for both U.S. military sales and foreign military sales (FMS), combined with some shifting in defense spending budget allocations in US military sales and FMS away from Army ground system vehicles toward other military agency applications. Due to the significant level of uncertainty surrounding the pandemic and its impact to our customers and the defense supply chain, we are unable to ascertain the impact further delays in contract awards and customer orders may have on our total fiscal year 2021 revenues. We have experienced a reduction of 32% in revenue volume during the first six months of fiscal year 2021, as compared to the first six months of fiscal year 2020. We have experienced a recent increase in proposal requests, and anticipate an increase in orders over the next six to twelve months, however the timing and nature of new orders in the near term cannot be determined. Any continued delays in customer orders over the next three months could further impact our total fiscal year 2021 revenue and profitability during the second half. We have implemented several cost-saving initiatives during the first and second quarters, including reductions in force, employee compensation and discretionary spending. We are reviewing additional cost reductions during the next sixty to ninety days as required to further minimize the impact of any sustained delays in customer orders beyond the first six months of fiscal year 2021. Note 2 - Accounting Policies Basis of Presentation Principles of Consolidation: The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Optex Systems, Inc. All significant inter-company balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements of Optex Systems Holdings included herein have been prepared by Optex Systems Holdings, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in conjunction with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. F- 6 These condensed consolidated financial statements should be read in conjunction with the annual audited consolidated financial statements and the notes thereto included in the Optex Systems Holdings’ Form 10-K for the year ended September 27, 2020 and other reports filed with the SEC. The accompanying unaudited interim condensed consolidated financial statements reflect all adjustments of a normal and recurring nature which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows of Optex Systems Holdings for the interim periods presented. The results of operations for these periods are not necessarily comparable to, or indicative of, results of any other interim period or for the fiscal year taken as a whole. Certain information that is not required for interim financial reporting purposes has been omitted. Leases: On January 11, 2021 the Company executed amendments for each of the leased facilities extending the terms for eighty-six (86) months, commencing at the end of the current lease agreements. The Richardson lease amendment commences on April 1, 2021 for an eighty-six (86) month term ending on May 31, 2028. The Dallas lease amendment commences on November 1, 2021 for an eighty-six (86) month term ending on December 31, 2028. Each of the leases include two full months of rent abatement at the beginning of the commencement term. Execution of the new lease amendments resulted in the balance sheet recognition of a right-of-use asset of $3.7 million and corresponding operating lease liabilities of approximately $3.7 million during the three months ended March 28, 2021. See also Note 4. Inventory: As of March 28, 2021, and September 27, 2020, inventory included: (Thousands) March 28, 2021 September 27, 2020 Raw Material $ 4,855 $ 5,506 Work in Process 3,974 3,214 Finished Goods 731 638 Gross Inventory $ 9,560 $ 9,358 Less: Inventory Reserves (567 ) (567 ) Net Inventory $ 8,993 $ 8,791 Concentration of Credit Risk: Optex Systems Holdings’ accounts receivables for the period ended March 28, 2021 are derived from revenues of U.S. government agencies: 16%, three major U.S. defense contractors: 46%, 11% and 9%, one commercial customer: 5%, and all other customers: 13%. The Company does not believe that this concentration results in undue credit risk because of the financial strength of and its long history with these customers. Accrued Warranties: Optex Systems Holdings accrues product warranty liabilities based on the historical return rate against period shipments as they occur and reviews and adjusts these accruals quarterly for any significant changes in estimated costs or return rates. The accrued warranty liability includes estimated costs to repair or replace returned warranty backlog units currently in-house plus estimated costs for future warranty returns that may be incurred against warranty covered products previously shipped as of the period end date. As of March 28, 2021, and September 27, 2020, the Company had warranty reserve balances of $63 thousand and $83 thousand, respectively. Three months ended Six months ended March 28, 2021 March 29, 2020 March 28, 2021 March 29, 2020 Beginning balance $ 49 $ 75 $ 83 $ 46 Incurred costs for warranties satisfied during the period (25 ) (68 ) - Warranty Expenses: Warranties reserved for new product shipped during the period (1) 5 36 9 56 Change in estimate for pre-existing warranty liabilities (2) 34 (6 ) 39 3 Warranty Expense 39 30 48 59 Ending balance $ 63 $ 105 $ 63 $ 105 (1) Warranty expenses accrued to cost of sales (based on current period shipments and historical warranty return rate. (2) Changes in estimated warranty liabilities for associated with the period end customer returned warranty backlog or repaired/replaced warranty units which were shipped to the customer during the period. F- 7 Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates. Fair Value of Financial Instruments: Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of the financial statement presentation date. The carrying value of cash and cash equivalents, accounts receivable and accounts payable, are carried at, or approximate, fair value as of the reporting date because of their short-term nature. The credit facility is reported at fair value as it bears market rates of interest. Fair values for the Company’s warrant liabilities and derivatives are estimated by utilizing valuation models that consider current and expected stock prices, volatility, dividends, market interest rates, forward yield curves and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates that may change in the future. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions. The accounting guidance establishes a hierarchy which requires an entity to maximize the use of quoted market prices and minimize the use of unobservable inputs. An asset or liability’s level is based on the lowest level of input that is significant to the fair value measurement. Fair value estimates are reviewed at the origination date and again at each applicable measurement date and interim or annual financial reporting dates, as applicable for the financial instrument, and are based upon certain market assumptions and pertinent information available to management at those times. The methods and significant inputs and assumptions utilized in estimating the fair value of the warrant liabilities, as well as the respective hierarchy designations are discussed further in Note 6 “Warrant Liabilities”. The warrant liability measurement is considered a Level 3 measurement based on the availability of market data and inputs and the significance of any unobservable inputs as of the measurement date. Revenue Recognition: The majority of the Company’s contracts and customer orders originate with fixed determinable unit prices for each deliverable quantity of goods defined by the customer order line item (performance obligation) and include the specific due date for the transfer of control and title of each of those deliverables to the customer at pre-established payment terms, which are generally within thirty to sixty days from the transfer of title and control. We have elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods. In addition, the Company has one ongoing service contract which began in October 2017 which relates to optimized weapon system support (OWSS) and includes ongoing program maintenance, repairs and spare inventory support for the customer’s existing fleet units in service over a three-year period. Revenue recognition for this program has been recorded by the Company, and compensated by the customer, at fixed monthly increments over time, consistent with the defined contract maintenance period. During the three and six months ended March 28, 2021 and March 29, 2020, there was $120 thousand and $240 thousand in 2021 and $113 thousand and $226 thousand in 2020 in service contract revenue recognized over time. F- 8 During the three and six-month periods ended March 28, 2021 and March 29, 2020, there was $0 and $1 thousand in 2021 and $3 and $3 thousand in 2020 of revenue recognized from customer deposit liabilities (deferred contract revenue). As of March 28, 2021, there are no customer deposit liabilities. As of the six months ended March 28, 2021, there are no sales commissions or other significant deferred contract costs. Income Tax/Deferred Tax: As of March 28, 2021 and September 27, 2020, Optex Systems, Inc. has a deferred tax asset valuation allowance of $1.0 million against deferred tax assets of $1.2 million. The valuation allowance has been established due to historical losses resulting in a Net Operating Loss Carryforward for each of the fiscal years 2011 through 2016 which may not be fully recognized due to an IRS Section 382 limitation related to a change in control. Earnings per Share: Basic earnings per share is computed by dividing income available for common shareholders (the numerator) by the weighted average number of common shares outstanding (the denominator) for the period. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. A significant number of our outstanding warrants are participating securities which share dividend distributions and the allocation of any undistributed earnings (deemed dividends) with our common shareholders. During the three and six months ended March 28, 2021, there were no declared dividends and $0 and $162 thousand in allocated undistributed earnings attributable to the participating warrants, respectively. During the three and six months ended March 29, 2020, there were no declared dividends, and $633 thousand and $413 thousand in undistributed earnings attributable to participating warrants, respectively. The Company has potentially dilutive securities outstanding which include unvested restricted stock units, stock options and warrants. In computing the dilutive effect of warrants, the numerator is adjusted to add back any deemed dividends on participating securities (warrants) and the denominator is increased to assume the conversion of the number of additional incremental common shares. The Company uses the Treasury Stock Method to compute the dilutive effect of any dilutive shares. Unvested restricted stock units, stock options and warrants that are anti-dilutive are excluded from the calculation of diluted earnings per common share. For the three months ended March 28, 2021, 99,000 unvested restricted stock units (which convert to 15,018 incremental shares) and 240,000 shares of unvested restricted stock (which convert to 36,407 incremental shares) were excluded in the diluted earnings per share calculation due to the net loss during the period. For the six months ended March 28, 2021, 99,000 unvested restricted stock units (which convert to 31,129 incremental shares) and 240,000 restricted shares (which convert to 81,755 incremental shares) were included in the diluted earnings per share calculation. For the three and six-months ended March 29, 2020, 182,000 unvested restricted stock units (which convert to 55,009 and 84,807 incremental shares for the three and six-months, respectively) were included in the diluted earnings per share calculation. For the three and six-months ended March 28, 2021 and the three and six-months ending March 29, 2020, 4,125,200 warrants were excluded from the diluted earnings per share calculation due to the antidilutive effect of the undistributed earnings. F- 9 Note 3 - Segment Reporting The Company’s reportable segments are strategic businesses offering similar products to similar markets and customers; however, the companies are operated and managed separately due to differences in manufacturing technology, equipment, geographic location, and specific product mix. Applied Optics Center was acquired as a unit, and the management at the time of the acquisition was retained. Both the Applied Optics Center and Optex Systems – Richardson operate as reportable segments under the Optex Systems, Inc. corporate umbrella. The Applied Optics Center segment also serves as the key supplier of laser coated filters used in the production of periscope assemblies for the Optex Systems-Richardson (“Optex Systems”) segment. Intersegment sales and transfers are accounted for at annually agreed to pricing rates based on estimated segment product cost, which includes segment direct manufacturing and general and administrative costs, but exclude profits that would apply to third party external customers. Optex Systems (OPX) – Richardson, Texas The Optex Systems segment revenue is comprised of approximately 85% domestic military customers and 15% foreign military customers. For the six months ending March 28, 2021, the Optex segment revenue is derived from the U.S. government, 25%, and two major U.S. defense contractors representing 24% and 13%, of the Company’s consolidated revenue, respectively. Optex Systems is located in Richardson Texas, with leased premises consisting of approximately 49,100 square feet. As of March 28, 2021, the Richardson facility operated with 53 full time equivalent employees in a single shift operation. Optex Systems, Richardson serves as the home office for both the Optex Systems and Applied Optics Center segments. Applied Optics Center (AOC) – Dallas, Texas The Applied Optics Center serves primarily domestic U.S. customers. Sales to commercial customers represent 22% and military sales to prime and subcontracted customers represent 78% of the external segment revenue. Approximately 76% of the AOC revenue is derived from external customers and approximately 24% is related to intersegment sales to Optex Systems in support of military contracts. For the six months ended March 28, 2021, the AOC segment revenue from two major defense contractors represents approximately 9%, and 7% of the Company’s consolidated revenue, respectively, and revenue from one commercial customer represents 5% of the Company’s consolidated revenue. The Applied Optics Center is located in Dallas, Texas with leased premises consisting of approximately 44,867 square feet of space. As of March 28, 2021, AOC operated with 32 full time equivalent employees in a single shift operation. The financial tables below present the information for each of the reportable segment’s profit or loss as well as segment assets for each year. The Company does not allocate interest expense, income taxes or unusual items to segments. F- 10 Reportable Segment Financial Information (thousands) Three months ended March 28, 2021 Optex Systems Richardson Applied Optics Center Dallas Other (non-allocated costs and intersegment eliminations) Consolidated Total Revenues from external customers $ 2,805 $ 1,441 $ - $ 4,246 Intersegment revenues - 530 (530 ) - Total Revenue $ 2,805 $ 1,971 $ (530 ) $ 4,246 Interest expense $ - $ - $ 2 $ 2 Depreciation and Amortization $ 10 $ 55 $ - $ 65 Loss before taxes $ (189 ) $ (168 ) $ (228 ) $ (585 ) Other significant noncash items: Allocated home office expense $ (153 ) $ 153 $ - $ - Loss on change in fair value of warrants $ - $ - $ 169 $ 169 Stock compensation expense $ - $ - $ 57 $ 57 Warranty Expense $ - $ 39 $ - $ 39 Segment Assets $ 14,820 $ 6,307 $ - $ 21,127 Expenditures for segment assets $ - $ 47 $ - $ 47 Reportable Segment Financial Information (thousands) Three months ended March 29, 2020 Optex Systems Richardson Applied Optics Center Dallas Other (non-allocated costs and intersegment eliminations) Consolidated Total Revenues from external customers $ 4,422 $ 2,525 $ - $ 6,947 Intersegment revenues - 407 (407 ) - Total Revenue $ 4,422 $ 2,932 $ (407 ) $ 6,947 Interest expense $ - $ - $ 6 $ 6 Depreciation and Amortization $ 8 $ 51 $ - $ 59 Income before taxes $ 568 $ 244 $ 1,295 $ 2,107 Other significant noncash items: Allocated home office expense $ (170 ) $ 170 $ - $ - Gain on Change in Fair Value of Warrants $ - $ - $ (1,332 ) $ (1,332 ) Stock option compensation expense $ - $ - $ 31 $ 31 Warranty Expense $ - $ 30 $ - $ 30 Segment Assets $ 12,793 $ 6,784 $ - $ 19,577 Expenditures for segment assets $ 33 $ 34 $ - $ 67 F- 11 Reportable Segment Financial Information (thousands) Six months ended March 28, 2021 Optex Systems Richardson Applied Optics Center Dallas Other (non-allocated costs and intersegment eliminations) Consolidated Total Revenues from external customers $ 5,833 $ 2,884 $ - $ 8,717 Intersegment revenues - 896 (896 ) - Total Revenue $ 5,833 $ 3,780 $ (896 ) $ 8,717 Interest expense $ - $ - $ 5 $ 5 Depreciation and Amortization $ 21 $ 107 $ - $ 128 Income (loss) before taxes $ 24 $ (245 ) $ 739 $ 518 Other significant noncash items: Allocated home office expense $ (353 ) $ 353 $ - $ - Gain on change in fair value of warrants $ - $ - $ (858 ) $ (858 ) Stock compensation expense $ - $ - $ 114 $ 114 Warranty expense $ - $ 48 $ - $ 48 Segment Assets $ 14,820 $ 6,307 $ - $ 21,127 Expenditures for segment assets $ 20 $ 108 $ - $ 128 Reportable Segment Financial Information (thousands) Six months ended March 29, 2020 Optex Systems Richardson Applied Optics Center Dallas Other (non-allocated costs and intersegment eliminations) Consolidated Total Revenues from external customers $ 8,066 $ 4,767 $ - $ 12,833 Intersegment revenues - 780 (780 ) - Total Revenue $ 8,066 $ 5,547 $ (780 ) $ 12,833 Interest expense $ - $ - $ 11 $ 11 Depreciation and Amortization $ 15 $ 110 $ - $ 125 Income before taxes $ 1,050 $ 506 $ 13 $ 1,569 Other significant noncash items: Allocated home office expense $ (340 ) $ 340 $ - $ - Gain on change in fair value of warrants $ - $ - $ (81 ) $ (81 ) Stock option compensation expense $ - $ - $ 57 $ 57 Warranty Expense $ - $ 59 $ - $ 59 Segment Assets $ 12,793 $ 6,784 $ - $ 19,577 Expenditures for segment assets $ 46 $ 50 $ - $ 96 F- 12 Note 4 - Commitments and Contingencies Non-cancellable Operating Leases Optex Systems Holdings leases its office and manufacturing facilities for the Optex Systems, Inc., Richardson address and the Applied Optics Center Dallas address, as well as certain office equipment under non-cancellable operating leases. The leased facility under Optex Systems Inc. at 1420 Presidential Drive, Richardson, Texas consists of 49,100 square feet of space. The previous lease expired March 31, 2021 and the monthly base rent was $24.6 thousand through March 31, 2021. On January 11, 2021 the Company executed a sixth amendment extending the terms of its Optex Systems, Richardson location lease for eighty-six (86) months, commencing on April 1, 2021 and ending on May 31, 2028. The initial base rent is set at $25.3 thousand and escalates 3% each year thereafter on April 1, each year. The initial term includes 2 months of rent abatement for April and May 2021. The monthly rent includes approximately $11.6 thousand for additional Common Area Maintenance (CAM) fees and taxes, to be adjusted annually based on actual expenses incurred by the landlord. The leased facility under the Applied Optics Center at 9839 and 9827 Chartwell Drive, Dallas, Texas, consists of 44,867 square feet of space at the premises. The current lease term will expire on October 31, 2021. The monthly base rent is $21.9 thousand through October 31, 2021. Our obligations to make payments under the lease are secured by a $125,000 standby letter of credit. On January 11, 2021 the Company executed a first amendment extending the terms of its current Applied Optics Center, Dallas location lease for eighty-six (86) months, commencing on November 1, 2021 and ending on December 31, 2028. The initial base rent is set at $23.6 thousand as of January 1, 2022 and escalates 2.75% each year thereafter on January 1, each year. The initial term includes 2 months of rent abatement for November and December of 2021. The amendment provides for a five-year renewal option at the end of the lease term at the greater of the then “prevailing rental rate” or the then current base rent rate. The monthly rent includes approximately $7.8 thousand for additional CAM, to be adjusted annually based on actual expenses incurred by the landlord. The Company has one non-cancellable office equipment lease with a commencement date of October 1, 2018 and a term of 39 months. The lease cost for the equipment is $1.5 thousand per month from October 1, 2018 through December 31, 2021. Optex Systems Holdings adopted the provisions of ASC Topic 842 “Leases” as of the fiscal year beginning on September 30, 2019. Optex Systems Holdings has two significant operating facilities leases and one equipment lease which extends beyond twelve months and fall under the guidance of ASC Topic 842. Adoption of ASC Topic 842 resulted in the balance sheet recognition of a right-of-use asset of $1.8 million and corresponding operating lease liabilities of approximately $1.9 million as of September 30, 2019, which represented the present value of future lease payments for the term of the equipment lease and both segment facility leases and which assumed the exercise of a five-year renewal option at the Applied Optics Center as of November 1, 2021. Execution of the new lease amendments for the Dallas and Richardson facilities on January 11, 2021 resulted in the balance sheet recognition of a right-of-use asset of $3.7 million and corresponding operating lease liabilities of approximately $3.7 million during the three months ended March 28, 2021. F- 13 As of March 28, 2021, the remaining minimum lease and estimated CAM payments under the non-cancelable office and facility space leases are as follows: Non-cancellable Operating Leases (Thousands) Optex Richardson Applied Optics Center Office Equipment Consolidated Fiscal Year Facility Lease Payments Facility Lease Payments Lease Payments Total Lease Payments Total Variable CAM Estimate 2021 Base year lease $ 101 $ 131 $ 9 $ 241 $ 116 2022 Base year lease 308 234 5 547 237 2023 Base year lease 317 288 605 242 2024 Base year lease 327 296 623 247 2025 Base year lease 336 305 641 252 2026 Base year lease 346 313 659 257 2027 Base year lease 357 322 679 262 2028 Base year lease 241 330 571 188 2029 Base year lease - 83 83 27 Total base lease payments $ 2,333 $ 2,302 $ 14 $ 4,649 $ 1,828 Imputed interest on lease payments (1) (387 ) (410 ) (1 ) (798 ) Total Operating Lease Liability (2) $ 1,946 $ 1,892 $ 13 $ 3,851 Right-of-use Asset (3) $ 1,946 $ 1,883 $ 13 $ 3,842 (1) Assumes a discount borrowing rate of 5.0% on the new lease amendments effective as of January 11, 2021 and 7.5% on the remaining lease term for the Applied Optics Dallas facility through October 31, 2021. (2) Short-term and Long-term portion of Operating Lease Liability is $477 thousand and $3,374 thousand, respectively. (3) Includes $9 thousand of unamortized deferred rent for the Applied Optics Lease term expiring on October 31, 2021. Total facilities rental and CAM expense for both facility lease agreements as of the three and six months ended March 28, 2021 was $183 thousand and $361 thousand, respectively. Total facilities rental and CAM expense for both facility lease agreements as of the three and six months ended March 29, 2020 was $179 thousand and $354 thousand, respectively. Total office equipment rentals included in operating expenses was $5 thousand and $9 thousand for the three and six months ended March 28, 2021, respectively. Total office equipment rentals included in operating expenses was $6 thousand and $12 thousand for the three and six months ended March 29, 2020, respectively. F- 14 Note 5 - Debt Financing Credit Facility On April 16, 2020, the Company terminated its facility with Avidbank and entered into a new facility with BBVA USA. On April 16, 2020, Optex Systems Holdings, Inc. and its subsidiary, Optex Systems, Inc. (“Optex”, and with the Company, the “Borrower”) entered into a line of credit facility (the “Facility”) with BBVA, USA (“BBVA”) The substantive terms are as follows: ● The principal amount of the Facility is $2.25 million. The Facility matures on April 15, 2022. The interest rate is variable based on BBVA’s Prime Rate plus a margin of -0.250%, initially set at 3% at loan origination, and all accrued and unpaid interest is payable monthly in arrears starting on May 15, 2020; and the principal amount is due in full with all accrued and unpaid interest and any other fees on April 15, 2022. ● There are commercially standard covenants including, but not limited to, covenants regarding maintenance of corporate existence, not incurring other indebtedness except trade debt, not changing more than 25% stock ownership of Borrower, and a Fixed Charge Coverage Ratio of 1.25:1, with the Fixed Charge Coverage Ratio defined as (earnings before taxes, amortization, depreciation, amortization and rent expense less cash taxes, distribution, dividends and fair value of warrants) divided by (current maturities on long term debt plus interest expense plus rent expense). As of March 28, 2021, the Company was in compliance with the covenants. ● The Facility contains commercially standard events of default including, but not limited to, not making payments when due; incurring a judgment of $10,000 or more not covered by insurance; not maintaining collateral and the like. ● The Facility is secured by a first lien on all of the assets of Borrower. The outstanding balance on the facility was $377 thousand as of March 28, 2021 and September 27, 2020. Note 6-Warrant Liabilities On August 26, 2016, Optex Systems Holdings, Inc. issued 4,323,135 warrants to new shareholders and the underwriter, in connection with a public share offering. The warrants entitle the holder to purchase one share of our common stock at an exercise price equal to $1.50 per share at any time on or after August 26, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on August 26, 2021 (the “Termination Date”). The Company determined that these warrants are free standing financial instruments that are legally detachable and separately exercisable from the common stock included in the public share offering. Management also determined that the warrants are puttable for cash upon a fundamental transaction at the option of the holder and as such required classification as a liability pursuant to ASC 480 “Distinguishing Liabilities from Equity” . The Company has no plans to consummate a fundamental transaction and does not believe a fundamental transaction is likely to occur during the remaining term of the outstanding warrants. In accordance with the accounting guidance, the outstanding warrants are recognized as a warrant liability on the balance sheet and are measured at their inception date fair value and subsequently re-measured at each reporting period with changes being recorded as a component of other income in the consolidated statements of operations. F- 15 The fair value of the warrant liabilities presented below were measured using a Black Scholes Merton (BSM) valuation model. Significant inputs into the respective model at the reporting period measurement dates are as follows: Valuation Assumptions Period ended September 29, 2019 Period ended September 27, 2020 Period ended March 29, 2020 Period ended March 28, 2021 Exercise Price (1) $ 1.50 $ 1.50 $ 1.50 $ 1.50 Warrant Expiration Date (1) 8/26/2021 8/26/2021 8/26/2021 8/26/2021 Stock Price (2) $ 1.56 $ 1.96 $ 1.67 $ 1.84 Interest Rate (annual) (3) 1.63 % 0.12 % 0.33 % 0.04 % Volatility (annual) 53.66 % 51.67 % 51.04 % 45.12 % Time to Maturity (Years) 1.9 0.9 1.4 0.4 Calculated fair value per share $ 0.49 $ 0.62 $ 0.47 $ 0.41 ( 1) Based on the terms provided in the warrant agreement to purchase common stock of Optex Systems Holdings, Inc. dated August 26, 2016. (2) Based on the trading value of common stock of Optex Systems Holdings, Inc. as of each presented period ended date. (3) Interest rate for U.S. Treasury Bonds as each presented period ended date, as published by the U.S. Federal Reserve. The warrants outstanding and fair values at each of the respective valuation dates are summarized below: Warrant Liability Warrants Outstanding Fair Value per Share Fair Value (000’s) Fair Value as of period ended 9/29/2019 4,125,200 $ 0.49 $ 2,036 Gain on Change in Fair Value of Warrant Liability (81 ) Fair Value as of period ended 3/29/2020 4,125,200 $ 0.47 1,955 Fair Value as of period ended 9/27/2020 4,125,200 $ 0.62 $ 2,544 Gain on Change in Fair Value of Warrant Liability (858 ) Fair Value as of period ended 3/28/2021 4,125,200 $ 0.41 $ 1,686 During the three and six months ended March 28, 2021 and March 29, 2020, there were no new issues or exercises of existing warrants. The warrant liabilities are considered Level 3 liabilities on the fair value hierarchy as the determination of fair value includes various assumptions about future activities and the Company’s stock prices and historical volatility as inputs. Note 7-Stock Based Compensation Stock Options issued to Employees, Officers and Directors The Optex Systems Holdings 2009 Stock Option Plan provides for the issuance of up to 75,000 shares to the Company’s officers, directors, employees and to independent contractors who provide services to Optex Systems Holdings as either incentive or non-statutory stock options determined at the time of grant. There were no new grants of stock options during the three months ended March 28, 2021. As of March 28, 2021, there are zero stock options outstanding. F- 16 Restricted Stock Units issued to Officers and Employees The following table summarizes the status of Optex Systems Holdings’ aggregate non-vested restricted stock units granted under the Company’s 2016 Restricted Stock Unit Plan: Restricted Stock Units Weighted Average Grant Date Fair Value Restricted Shares Weighted Average Grant Date Fair Value Outstanding at September 29, 2019 216,500 $ 1.29 — — Granted 50,000 $ 2.13 300,000 $ 1.75 Vested (84,500 ) $ 1.25 — — Forfeited - — — — Outstanding at September 27, 2020 182,000 $ 1.54 300,000 $ 1.75 Granted — — — — Vested (83,000 ) 1.49 (60,000 ) 1.75 Forfeited — — — — Outstanding at March 28, 2021 99,000 $ 1.59 240,000 $ 1.75 On February 17, 2020, the Company granted 50,000 restricted stock units to Bill Bates, General Manager of the Applied Optics Center. The restricted stock units vest as of January 1 each year subsequent to the grant date over a three-year period at a rate of 34% in year one, and 33% each year thereafter. The stock price at grant date was $2.13 per share. The Company will amortize the grant date fair market value of $107 thousand to stock compensation expense on a straight-line basis across the three-year vesting period beginning on February 17, 2020. On January 7, 2020, the Company issued 59,447 common shares to one director and two officers, net of tax withholding of $54 thousand, in settlement of 84,500 restricted stock units which vested on January 1, 2020. On January 2, 2021, the Company issued 58,392 common shares to directors and officers, net of tax withholding of $44 thousand, in settlement of 83,000 restricted stock units which vested on January 1, 2021. On April 30, 2020, the Optex Systems Holdings, Inc. Board of Directors held a meeting and voted to increase the annual board compensation for the three independent directors from $22,000 to $36,000 with an effective date of January 1, 2020, in addition to granting 100,000 restricted shares to each independent director which shall vest at a rate of 20% per year (20,000 shares) each January 1 st , over the next five years, through January 1, 2025. The total market value for the 300,000 shares is $525 thousand based on the stock price of $1.75 as of April 30, 2020. The Company will amortize the fair market value to stock compensation expense on a straight-line basis across the five-year vesting period beginning on April 30, 2020. On January 1, 2021, 60,000 of the restricted director shares vested. Stock Based Compensation Expense Equity compensation is amortized based on a straight-line basis across the vesting or service period as applicable. The recorded compensation costs for options and shares granted and restricted stock units awarded as well as the unrecognized compensation costs are summarized in the table below: Stock Compensation (thousands) Recognized Compensation Expense Unrecognized Compensation Expense Three months ended Six months ended As of period ended March 28, 2021 March 29, 2020 March 28, 2021 March 29, 2020 March 28, 2021 September 27, 2020 Restricted Shares $ 26 $ - $ 52 $ - $ 394 $ 446 Restricted Stock Units 31 31 62 57 127 188 Total Stock Compensation $ 57 $ 31 $ 114 $ 57 $ 521 $ 634 F- 17 Note 8 Stockholders’ Equity Dividends As of the six months ended March 28, 2021 and the twelve months ended September 27, 2020, there were no declared or outstanding dividends payable. Common stock On June 8, 2020 the Company announced authorization for a $1 million stock repurchase program. The shares authorized to be repurchased under the new repurchase program may be purchased from time to time at prevailing market prices, through open market or in negotiated transactions, depending upon market conditions and subject to Rule 10b-18 as promulgated by the SEC. During the six months ended March 28, 2021, there were 374,934 common shares repurchased through the program at a cost of $730 thousand. As of March 28, 2021, the Company has repurchased 480,667 shares at a total cost of $930 thousand against the stock repurchase plan, with a remaining balance of $70 thousand. The shares have been returned to the Treasury. A summary of the purchases under the plan follows: (Thousands, except share and price per share data) Fiscal Period Total number of shares purchased Total purchase cost Average price paid per share (with commission) Maximum dollar value that may yet be purchased under the plan May 24, 2020 through June 28, 2020 34,243 $ 63 $ 1.84 $ 937 June 29, 2020 through July 26, 2020 6,806 13 1.89 924 July 27, 2020 through August 23, 2020 10,688 21 1.96 903 August 23, 2020 through September 27, 2020 53,996 103 1.90 800 Total shares repurchased as of September 27, 2020 105,733 $ 200 $ 1.89 $ 800 September 28, 2020 through October 25, 2020 20,948 42 2.01 758 October 26, 2020 through November 22, 2020 129,245 265 2.05 493 November 23, 2020 through December 27, 2020 58,399 109 1.86 384 December 28, 2020 through January 24, 2021 40,362 73 1.80 312 January 25, 2021 through February 21, 2021 52,180 101 1.94 211 February 22, 2021 through March 28, 2021 73,800 140 1.90 70 Total shares repurchased as of March 28, 2021 480,667 $ 930 $ 1.93 $ 70 As of September 27, 2020, and March 28, 2021, the total outstanding common shares were 8,690,136 and 8,373,594, respectively. As of September 27, 2020, and March 28, 2021, the total issued common shares were 8,795,869 and 8,854,261. Note 9 Subsequent Events None. F- 18 ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Management’s Discussion and Analysis or Plan of Operations This MD&A is intended to supplement and complement our audited condensed consolidated financial statements and notes thereto for the fiscal year ended September 27, 2020 and our reviewed but unaudited consolidated financial statements and footnotes thereto for the quarter ended March 28, 2021, prepared in accordance with U.S. generally accepted accounting principles (GAAP). You are encouraged to review our consolidated financial statements in conjunction with your review of this MD&A. The financial information in this MD&A has been prepared in accordance with GAAP, unless otherwise indicated. In addition, we use non-GAAP financial measures as supplemental indicators of our operating performance and financial position. We use these non-GAAP financial measures internally for comparing actual results from one period to another, as well as for planning purposes. We will also report non-GAAP financial results as supplemental information, as we believe their use provides more insight into our performance. When non-GAAP measures are used in this MD&A, they are clearly identified as non-GAAP measures and reconciled to the most closely corresponding GAAP measure. The following discussion highlights the principal factors that have affected our financial condition and results of operations as well as our liquidity and capital resources for the periods described. This discussion contains forward-looking statements. Please see “Special cautionary statement concerning forward-looking statements” and “Risk factors” for a discussion of the uncertainties, risks and assumptions associated with these forward-looking statements. The operating results for the periods presented were not significantly affected by inflation. Background Optex Systems, Inc. (Delaware) manufactures optical sighting systems and assemblies, primarily for Department of Defense applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and armored security vehicles and have been selected for installation on the Stryker family of vehicles. Optex Systems, Inc. (Delaware) also manufactures and delivers numerous periscope configurations, rifle and surveillance sights and night vision optical assemblies. Optex Systems, Inc. (Delaware) products consist primarily of build-to-customer print products that are delivered both directly to the armed services and to other defense prime contractors. Less than 1% of today’s revenue is related to the resale of products substantially manufactured by others. In this case, the product would likely be a simple replacement part of a larger system previously produced by Optex Systems, Inc. (Delaware). We are both a prime and sub-prime contractor to the Department of Defense. Sub-prime contracts are typically issued through major defense contractors such as General Dynamics Land Systems, Raytheon Corp., BAE, NorcaTec and others. We are also a military supplier to foreign governments such as Israel, Australia and NAMSA and South American countries and as a subcontractor for several large U.S. defense companies serving foreign governments. By way of background, the Federal Acquisition Regulation is the principal set of regulations that govern the acquisition process of government agencies and contracts with the U.S. government. In general, parts of the Federal Acquisition Regulation are incorporated into government solicitations and contracts by reference as terms and conditions effecting contract awards and pricing solicitations . Many of our contracts are prime or subcontracted directly with the Federal government and, as such, are subject to Federal Acquisition Regulation Subpart 49.5, “Contract Termination Clauses” and more specifically Federal Acquisition Regulation clauses 52.249-2 “Termination for Convenience of the Government (Fixed-Price)”, and 49.504 “Termination of fixed-price contracts for default”. These clauses are standard clauses on our prime military contracts and generally apply to us as subcontractors. It has been our experience that the termination for convenience is rarely invoked, except where it is mutually beneficial for both parties. We are currently not aware of any pending terminations for convenience or for default on our existing contracts. In the event a termination for convenience were to occur, Federal Acquisition Regulation clause 52.249-2 provides for full recovery of all contractual costs and profits reasonably occurred up to and as a result of the terminated contract. In the event a termination for default were to occur, we could be liable for any excess cost incurred by the government to acquire supplies from another supplier similar to those terminated from us. We would not be liable for any excess costs if the failure to perform the contract arises from causes beyond the control and without the fault or negligence of the Company as defined by Federal Acquisition Regulation clause 52.249-8. 3 In addition, some of our contracts allow for government contract financing in the form of contract progress payments pursuant to Federal Acquisition Regulation 52.232-16, “Progress Payments”. As a small business, and subject to certain limitations, this clause provides for government payment of up to 90% of incurred program costs prior to product delivery. To the extent our contracts allow for progress payments, we intend to utilize this benefit, thereby minimizing the working capital impact on Optex Systems Holdings for materials and labor required to complete the contracts. We may be at risk as a result of the current COVID-19 pandemic. Risks that could affect our business include the duration and scope of the COVID-19 pandemic and the impact on the demand for our products; actions by governments, businesses and individuals taken in response to the pandemic; the length of time of the COVID-19 pandemic and the possibility of its reoccurrence; the timing required to develop effective treatments and to distribute effective vaccines to the general population; the eventual impact of the pandemic and actions taken in response to the pandemic on global and regional economies; and the pace of recovery when the COVID-19 pandemic subsides. Due to the significant level of uncertainty surrounding the pandemic and its impact to our customers and the defense supply chain, we are unable to ascertain the impact further delays in contract awards and customer orders may have on our total fiscal year 2021 revenues. We have realized a reduction of 32% in revenue volume during the first six months of fiscal year 2021, as compared to the first six months of fiscal year 2020. We have experienced a recent increase in proposal requests, and anticipate an increase in orders over the next six to twelve months, however the timing and nature of new orders in the near term cannot be determined. Any continued delays in customer orders over the next three months could further impact our total fiscal year 2021 revenue and profitability during the second half. We have implemented several cost-saving initiatives during the first and second quarters, including reductions in force, employee compensation and cuts in discretionary spending. We are reviewing additional cost reductions during the next sixty to ninety days as required to further minimize the impact of any sustained delays in customer orders beyond the first half of fiscal year 2021. Optex Systems Holdings, Inc. is defined as essential critical infrastructure as a defense contractor under the guidance of the federal, state and local authorities for both our Optex Systems (Richardson, TX), and Applied Optics Center (Dallas, TX) operating segments. As such, the Company continued to remain open during the COVID-19 shelter in place orders and closures. To date, we have experienced minimal workforce disruption as a result of the pandemic. Recent Events Employment Agreements We entered into an updated employment agreement with Danny Schoening dated October 15, 2020. The term of the agreement commenced as of October 15, 2020 and the current term ends on November 30, 2021. Mr. Schoening’s base salary continues to be $284,645 per annum. Mr. Schoening will be eligible for a performance bonus which is based upon a rolling three-year operating plan adopted by our Board of Directors. The bonus will be tied to operating metrics decided by our board against the three-year plan, and such metrics will be decided annually and tie to the three-year plan. The target bonus equates to 30% of Mr. Schoening’s base salary. Our board will have discretion to alter the performance bonus upward or downward by 20% based on its good faith discretion. The employment agreement events of termination consist of: (i) death or permanent disability of Mr. Schoening; (ii) termination by us for cause (including conviction of a felony, commission of fraudulent acts, willful misconduct by Mr. Schoening, continued failure to perform duties after written notice, violation of securities laws and breach of the employment agreement), (iii) termination without cause by us and (iv) termination by Mr. Schoening for good reason (including breach by us of its obligations under the agreement, the requirement for Mr. Schoening to move more than 100 miles away for his employment without consent, and merger or consolidation that results in more than 66% of the combined voting power of the then outstanding securities of us or our successor changing ownership or a sale of all or substantially all of our assets, without the surviving entity assuming the obligations under the agreement). For a termination by us for cause or upon death or permanent disability of Mr. Schoening, Mr. Schoening shall be paid salary and for a termination due to his death or permanent disability, also any bonus earned through the date of termination. For a termination by us without cause or by Mr. Schoening with good reason, Mr. Schoening shall also be paid six months’ base salary in effect. 4 On December 15, 2020, the Company’s Board of Directors approved executive bonuses for Danny Schoening, CEO, of $48 thousand which was paid in January, 2021, and Karen Hawkins, CFO, of $37 thousand which was paid in December 2020. On February 1, 2021, the employment agreement for Karen Hawkins, CFO, auto-renewed for an additional 18-month period, expiring on June 30, 2022. The contract automatically renews for subsequent 18-month periods unless Ms. Hawkins or the Company give notice of termination at least 90 days before the end of the term then in effect. Board Changes On April 30, 2020, the Optex Systems Holdings, Inc. Board of Directors held a meeting and voted to increase the annual board compensation for the three independent directors from $22,000 to $36,000 with an effective date of January 1, 2020, in addition to granting 100,000 restricted shares to each independent director which shall vest at a rate of 20% per year (20,000 shares) each January 1st, over the next five years, through January 1, 2025. The total market value for the 300,000 shares is $525 thousand based on the stock price of $1.75 as of April 30, 2020. On January 1, 2021, 60,000 of the restricted shares were vested. Stock & Warrant Repurchases On June 8, 2020 the Company announced authorization for a $1 million stock repurchase program. The shares authorized to be repurchased under the new repurchase program may be purchased from time to time at prevailing market prices, through open market or in negotiated transactions, depending upon market conditions and subject to Rule 10b-18 as promulgated by the SEC. During the year ended September 27, 2020, there were 105,733 common shares repurchased through the program at a cost of $200 thousand. During the six months ended March 28, 2021, there were 374,934 common shares repurchased through the program at a cost of $730 thousand. As of March 28, 2021, the Company has repurchased 480,667 shares at a total cost of $930 thousand against the stock repurchase plan, with a remaining balance of $70 thousand. The shares have been returned to the Treasury. Recent Orders ● On November 12, 2019, the Company announced a multi-year Indefinite Delivery Indefinite Quantity (IDIQ) award from Defense Logistics Agency Land and Maritime for periscopes for up to $2.3 Million over a five-year period. ● On December 3, 2019 the Company announced a shared award for a maximum of $35 Million for Improved Commander Weapon System (ICWS) periscopes under a three-year Indefinite Delivery - Indefinite Quantity (IDIQ) contract with two additional optional years. Optex and another recipient have been awarded this shared award from Defense Logistics Agency, Land and Maritime. Each company’s portion of the award will depend on price and performance over the ordering periods. ● On January 22, 2020, the Company announced it has been awarded a $1.1 Million order as part of a multi-year strategic supplier agreement with a domestic manufacturer of premium optical devices. The products will be manufactured at the Applied Optics Center (AOC) Division of Optex Systems, Inc. ● On January 27, 2020, the Company announced a multi-year Indefinite Delivery Indefinite Quantity (IDIQ) award from Defense Logistics Agency Land and Maritime for periscopes for up to $3.6 million over a five-year period. ● On February 18, 2020, the Company announced a multi-year Indefinite Delivery Indefinite Quantity (IDIQ) award from Defense Logistics Agency Land and Maritime for periscopes for up to $9.2 million over a five-year period. ● On August 3, 2020, the Company announced a $2.0 Million order from a U. S. prime contractor for optical subassemblies for shipments starting in 2021. ● On January 11, 2021, the Company announced a contract for Laser Protected Periscopes for a base period of three years plus two one-year option years, not to exceed $14.4 million pursuant to an Indefinite Delivery - Indefinite Quantity (IDIQ) contract. 5 Results of Operations Non-GAAP Adjusted EBITDA We use adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) as an additional measure for evaluating the performance of our business as “net income” includes the significant impact of noncash valuation gains and losses on warrant liabilities, noncash compensation expenses related to equity stock issues, as well as depreciation, amortization, interest expenses and federal income taxes. We believe that Adjusted EBITDA is a meaningful indicator of our operating performance because it permits period-over-period comparisons of our ongoing core operations before the excluded items. Adjusted EBITDA is a financial measure not required by, or presented in accordance with GAAP. Adjusted EBITDA has limitations and should not be considered in isolation or a substitute for performance measures calculated under GAAP. This non-GAAP measure excludes certain cash expenses that we are obligated to make. In addition, other companies in our industry may calculate Adjusted EBITDA differently than we do or may not calculate it at all, which limits the usefulness of Adjusted EBITDA as a comparative measure. The tables below summarize our three and six-month operating results for the periods ended March 28, 2021 and March 29, 2020, in terms of both the GAAP net income measure and the non-GAAP Adjusted EBITDA measure. We believe that including both measures allows the reader to have a “complete picture” of our overall performance. (Thousands) Three months ended Six months ended March 28, 2021 March 29, 2020 March 28, 2021 March 29, 2020 Net Income (Loss) (GAAP) (602 ) 1,944 485 1,265 Add: Loss (Gain) on Change in Fair Value of Warrants 169 (1,332 ) (858 ) (81 ) Federal Income Tax Expense 17 163 33 304 Depreciation 65 59 128 125 Stock Compensation 57 31 114 57 Interest Expense 2 6 5 11 Adjusted EBITDA - Non GAAP (292 ) 871 (93 ) 1,681 Our adjusted EBITDA decreased by $1.1 million to ($0.3) million during the three months ended March 28, 2021 as compared to $0.9 million during the three months ended March 29, 2020. Adjusted EBITDA for the six-month period ended March 28, 2021 decreased by $1.8 million to ($0.1) million from $1.7 million in the prior year six-month period. The decrease in the three and six-month periods is primarily driven by lower revenue and gross margin across both operating segments. Operating segment performance is discussed in greater detail throughout the following sections. During the three months ended March 28, 2021, we recognized a loss on the change in fair value of warrants of $0.2 million as compared to a gain of $1.3 million in the prior year three-month period. During the six months ended March 28, 2021, we recognized a gain on the change in fair value of warrants of $0.9 million as compared to a gain of $0.1 million in the prior year six-month period. As this is a non-cash (gain) loss driven by the current fair market value of our outstanding warrants and unrelated to our core business operating performance, the change in fair value losses and gains have historically been excluded from our adjusted EBITDA calculations presented above. Further discussion regarding the changes in fair value of the warrants and the related warrant liability can be found under “Other (Expense) Income” in the three months comparative narratives of this report, as well as in Item 1, “Consolidated Financial Statements, Note 6 - Warrant Liabilities”. 6 Segment Information We have presented the operating results by segment to provide investors with an additional tool to evaluate our operating results and to have a better understanding of the overall performance of each business segment and its ability to perform in subsequent periods. Management of Optex Systems Holdings uses the selected financial measures by segment internally to evaluate its ongoing segment operations and to allocate resources within the organization accordingly. Segments are determined based on differences in products, location, internal reporting and how operational decisions are made. Management has determined that the Optex Systems, Richardson plant and the Applied Optics Center, Dallas plant are separately managed, organized, and internally reported as separate business segments. The table below provides a summary of selective statement of operations data by operating segment for the three and six months ended March 28, 2021 and March 29, 2020 reconciled to the Condensed Consolidated Results of Operations as presented in Item 1, “Condensed Consolidated Financial Statements.” Results of Operations Selective Financial Info (Thousands) Three months ended March 28, 2021 March 29, 2020 Optex Richardson Applied Optics Center Dallas Other (non-allocated costs and eliminations) Consolidated Optex Richardson Applied Optics Center Dallas Other (non-allocated costs and eliminations) Consolidated Revenue from External Customers $ 2,805 $ 1,441 $ - $ 4,246 $ 4,422 $ 2,525 $ - $ 6,947 Intersegment Revenues - 530 (530 ) - - 407 (407 ) - Total Segment Revenue 2,805 1,971 (530 ) 4,246 4,422 2,932 (407 ) 6,947 Total Cost of Sales 2,561 1,837 (530 ) 3,868 3,375 2,360 (407 ) 5,328 Gross Margin 244 134 - 378 1,047 572 - 1,619 Gross Margin % 8.7 % 6.8 % - 8.9 % 23.7 % 19.5 % - 23.3 % General and Administrative Expense 586 149 57 792 649 158 31 838 Segment Allocated G&A Expense (153 ) 153 - - (170 ) 170 - - Net General & Administrative Expense 433 302 57 792 479 328 31 838 Operating Income (Loss) (189 ) (168 ) (57 ) (414 ) 568 244 (31 ) 781 Operating Income (Loss) % (6.7 )% (8.5 )% - (9.8 )% 12.8 % 8.3 % - 11.2 % (Loss) Gain on Change in Fair Value of Warrants - - (169 ) (169 ) - - 1,332 1,332 Interest Expense - - (2 ) (2 ) - - (6 ) (6 ) Net Income (Loss) before taxes $ (189 ) $ (168 ) $ (228 ) $ (585 ) $ 568 $ 244 $ 1,295 $ 2,107 Net Income (Loss) % (6.7 )% (8.5 )% - (13.8 )% 12.8 % 8.3 % - 30.3 % Six months ended March 28, 2021 March 29, 2020 Optex Richardson Applied Optics Center Dallas Other (non-allocated costs and eliminations) Consolidated Optex Richardson Applied Optics Center Dallas Other (non-allocated costs and eliminations) Consolidated Revenue from External Customers $ 5,833 $ 2,884 $ - $ 8,717 $ 8,066 $ 4,767 $ - $ 12,833 Intersegment Revenues - 896 (896 ) - - 780 (780 ) - Total Segment Revenue 5,833 3,780 (896 ) 8,717 8,066 5,547 (780 ) 12,833 Total Cost of Sales 5,003 3,397 (896 ) 7,504 6,119 4,408 (780 ) 9,747 Gross Margin 830 383 - 1,213 1,947 1,139 - 3,086 Gross Margin % 14.2 % 10.1 % - 13.9 % 24.1 % 20.5 % - 24.0 % General and Administrative Expense 1,159 275 114 1,548 1,237 293 57 1,587 Segment Allocated G&A Expense (353 ) 353 - - (340 ) 340 - - Net General & Administrative Expense 806 628 114 1,548 897 633 57 1,587 Operating Income (Loss) 24 (245 ) (114 ) (335 ) 1,050 506 (57 ) 1,499 Operating Income (Loss) % 0.4 % (6.5 )% - (3.8 )% 13.0 % 9.1 % - 11.7 % Gain on Change in Fair Value of Warrants - - 858 858 - - 81 81 Interest Expense - - (5 ) (5 ) - - (11 ) (11 ) Net Income (Loss) before taxes $ 24 $ (245 ) $ 739 $ 518 $ 1,050 $ 506 $ 13 $ 1,569 Net Income (loss) before taxes % 0.4 % (6.5 )% - 5.9 % 13.0 % 9.1 % - 12.2 % 7 Our total revenues decreased by $2.7 and $4.1 million or 39% and 32% during the three and six months ended March 28, 2021, respectively, as compared to the three and six months ended March 29, 2020. Decreased revenue during the three and six months was driven by decreased external revenue of $1.6 and $2.2 million at the Optex Richardson and $1.1 and $1.9 million the Applied Optics Center, respectively, over the prior year period. We have experienced a reduction in customer demand driven by the pandemic, combined with shifting priorities in domestic and foreign military spending. While we are optimistic that our customer orders will return to pre-pandemic levels over the next twelve months, the timing and nature of new orders in the near term, as well has the impact on our full year revenue, primarily during the fourth quarter, cannot be fully determined. We currently anticipate a 26-32% reduction in our total fiscal year performance in 2021 as compared to the fiscal year performance of 2020. Consolidated gross margin decreased by $1.2 million and $1.9 million, or 76.7% and 60.7%, respectively during the three and six-months ending March 28, 2021 as compared to the prior year period. The decreased margin during the three and six-month periods is primarily attributable lower revenue across both segments, changes in product mix toward less profitable product groups, and unfavorable manufacturing overhead adjustments on reduced production volume. Optex Systems-Richardson, and the Applied Optics Center-Dallas, have substantial fixed manufacturing costs that are not easily adjusted as production levels decline. We have implemented cost reduction measures during the first and second quarters of fiscal year 2021, but do not expect to mitigate the impact of the revenue reductions on the operating gross margin for the year. We anticipate the margins will improve slightly during the second half as revenues increase and the impact of the first half cost reductions are fully realized. Our operating income decreased by $1.2 million and $1.8 million in the three and six months ended March 28, 2021, to losses of ($0.4) million and ($0.3) million, as compared to the prior year period operating income of $0.8 million and $1.5 million, respectively. The decreased three and six-month operating income is primarily driven by lower revenue and lower gross margin during the quarter with slightly lower general and administrative costs of $46 and $39 thousand during the current year three and six-month period. Backlog Backlog as of March 28, 2021, was $16.0 million as compared to a backlog of $16.3 million as of September 27, 2020, representing a decrease of $0.3 million or 1.8%. During the six months ended March 28, 2021 the Company booked $8.5 million in new orders as compared to $10.1 million during the six months ended March 29, 2020. The following table depicts the current expected delivery by period of all contracts awarded as of March 28, 2021 in millions of dollars: (Millions) Product Line Q3 2021 Q4 2021 2021 Delivery 2022+ Delivery Total Backlog 3/28/2021 Total Backlog 9/27/2020 Variance % Chg Periscopes $ 1.7 $ 1.1 $ 2.8 $ 2.0 $ 4.8 $ 5.3 $ (0.5 ) (9.4 )% Sighting Systems 0.7 0.5 1.2 0.7 1.9 2.9 (1.0 ) (34.5 )% Howitzer - 0.1 0.1 2.2 2.3 2.5 (0.2 ) (8.0 )% Other 0.7 0.5 1.2 0.4 1.6 2.5 (0.9 ) (36.0 )% Optex Systems - Richardson 3.1 2.2 5.3 5.3 10.6 13.2 (2.6 ) (19.7 )% Applied Optics Center - Dallas 1.4 2.3 3.7 1.7 5.4 3.1 2.3 74.2 % Total Backlog $ 4.5 $ 4.5 $ 9.0 $ 7.0 $ 16.0 $ 16.3 $ (0.3 ) (1.8 )% During the fiscal year 2020, we experienced a significant reduction in new orders and ending customer backlog across all but one of our product lines. We attribute the lower orders to a combination of factors including a COVID-19 driven slow-down of contract awards for both U.S. military sales and foreign military sales (FMS), combined with some shifting in defense spending budget allocations in US military sales and FMS away from Army ground system vehicles toward other military agency applications. Due to the pandemic, we have experienced a significant slowdown in the U.S. government procurement process increasing the cycle time from contract bid proposal requests to final contract award by three to six months. We believe many of the delays are process driven as government agencies adapt to new remote work environments, combined with constraints created by travel restrictions, impeding product testing, inspection and overall program management coordination. In addition, the pandemic has caused several program delays throughout the defense supply chain as a result of plant shutdowns, employee illnesses, travel restrictions, remote work arrangements and similar supplier issues. 8 Due to the significant level of uncertainty surrounding the pandemic and its impact to our customers and the defense supply chain, we are unable to ascertain the impact further delays in contract awards and customer orders may have on our total fiscal year 2021 revenues. We have experienced a reduction of 32% in revenue volume during the first six months of fiscal year 2021, as compared to the first six months of fiscal year 2020. We have experienced a recent increase in proposal requests, and anticipate an increase in orders over the next six to twelve months, however the timing and nature of new orders in the near term cannot be determined. Any continued delays in customer orders over the next three months could further impact our total fiscal year 2021 revenue and profitability during the second half. We have implemented several cost-saving initiatives during the first and second quarters, including reductions in force and employee compensation combined with cuts in other discretionary spending. We are reviewing additional cost reductions during the next sixty to ninety days as required to further minimize the impact of any sustained delays in customer orders beyond the first half of fiscal year 2021. Optex Systems - Richardson: During the six months ended March 28, 2021, backlog for the Optex Systems Richardson segment decreased by ($2.6) million, or (19.7%), to $10.6 million from the fiscal year-end backlog of $13.2 million. Decreased backlog in sighting systems, howitzers, and other product groups is primarily driven by shipments against several of our long running Commander Weapon Sighting Systems “CWSS”, Digital Day and Night Sighting Systems “DDAN” and Muzzle Reference Sensor Collimator Assembly “MRS” contracts. Decreases in the periscope backlog is primarily driven by shipments against our ICWS glass periscope order during the current fiscal year, completing the contract. During the six months ended March 28, 2021 we booked new periscope orders of $3.0 million, as compared to $5.6 million booked during the prior year six-month period ended March 29, 2020. On January 11, 2021, the Company announced a contract for Laser Protected Periscopes for a base period of three years plus two one-year option years, not to exceed $14.4 million pursuant to an Indefinite Delivery - Indefinite Quantity (IDIQ) contract. We anticipate additional periscope contracts in addition to task order awards against our existing nine active IDIQ contracts for delivery in 2021 and beyond. During the six months ended March 28, 2021, there were no new orders booked for howitzers or other products, as compared to $1.6 million booked during the six months ended March 29, 2020 and there was $0.3 million in new orders for sighting system contract modifications, as compared to $0.2 million of sighting system orders booked during the prior year six-month period. Applied Optics Center – Dallas During the six months ended March 28, 2021, the Applied Optics Center backlog increased by $2.3 million, or 74.2%, to $5.4 million from the fiscal year end level of $3.1 million. During the six months ended March 28, 2021, the Applied Optics Center booked new orders of $5.2 million as compared to $2.7 million in the prior year six- month period. We are seeing increases in demand and proposal activity for both laser coated filters and optical assemblies and anticipate additional order bookings for both our commercial and military products for deliveries beginning in the fourth quarter of fiscal year 2021. The Company continues to aggressively pursue international and commercial opportunities in addition to maintaining its current footprint with U.S. vehicle manufactures, with existing as well as new product lines. We are also reviewing potential products, outside our traditional product lines, which could be manufactured using our current production facilities in order to capitalize on our existing excess capacity. 9 Three Months Ended March 28, 2021 Compared to the Three Months Ended March 29, 2020 Revenues . In the three months ended March 28, 2021, revenues decreased by $2.7 million or 38.9% from the respective prior period in fiscal year 2020 as set forth in the table below: Three months ended (Thousands) Product Line March 28, 2021 March 29, 2020 Variance % Chg Periscopes $ 1,613 $ 3,030 $ (1,417 ) (46.8 ) Sighting Systems 405 242 163 67.4 Howitzers 95 - 95 - Other 692 1,150 (458 ) (39.8 ) Optical Systems - Richardson 2,805 4,422 (1,617 ) (36.6 ) Applied Optics Center - Dallas 1,441 2,525 (1,084 ) (42.9 ) Total Revenue $ 4,246 $ 6,947 $ (2,701 ) (38.9 ) Revenue on our periscope line decreased by $1.4 million or 46.8% on lower customer demand during the three months ended March 28, 2021 as compared to the three months ended March 29, 2020. Sighting systems revenue for the three months ending March 28, 2021 increased by $163 thousand or 67.4% from revenues in the prior year period on shipments against our CWSS programs not in the prior year three-month period. Other product revenue decreased by $458 thousand, or 39.8% during the three months ending March 28, 2021 as compared to the prior year period due to lower contract demand on MRS collimators and cell assemblies. Revenue increased by $95 thousand on our new Howitzer M137 spare program during the period as we completed first article during the first quarter and began contract deliveries in December, 2021. Applied Optics Center revenue decreased $1.1 million or 42.9% during the three months ended March 28, 2021 as compared to the three months ended March 29, 2020. The lower revenue was primarily driven by lower customer orders across coated filter and optical assembly lines. During the first half of fiscal year 2021, we have seen an increase in customer proposal requests and have booked an additional $5.2 million in new orders for optical assemblies and coated filters, including $0.6 million in new business from a new customer for delivery in 2021 and beyond. Gross Margin . The gross margin during the three-month period ending March 28, 2021 was 8.9% of revenue as compared to a gross margin of 23.3% of revenue for the period ending March 29, 2020. The decreased margin during the three-month period is primarily attributable lower revenue across both segments and unfavorable manufacturing overhead adjustments on reduced production volume. Cost of sales decreased to $3.9 million for the current period as compared to the prior year period of $5.3 million on lower period revenue. G&A Expenses . During the three months ended March 28, 2021 and March 29, 2020, we recorded operating expenses of $792 thousand and $838 thousand, respectively. Operating expenses decreased by 5.5% between the respective periods primarily due to lower spending in office supplies, travel and trade shows. Operating (Loss) Income . During the three months ended March 28, 2021, we recorded an operating loss of ($414) thousand, as compared to operating income of $781 thousand during the three months ended March 29, 2020. The $1.2 million decrease in operating income in the current year period over the prior year period is primarily due to decreased revenue and gross margin. Other (Expense) Income. During the three months ended March 28, 2021, we recognized a ($169) thousand loss on change in the fair value of warrants as compared to a $1.3 million gain in three months ending March 29, 2020. The current period loss in the fair value of warrants is primarily attributable to changes in the common stock volatility, US treasury rates, stock price and remaining warrant term from the prior period end. Additional information related to the change in valuation is discussed under Item 1, “Consolidated Financial Statements, Note 6 – Warrant Liability”. Net (Loss) Income applicable to common shareholders . During the three months ended March 28, 2021, we recorded a net loss applicable to common shareholders of ($0.6) million as compared to a net income applicable to common shareholders of $1.3 million during the three months ended March 29, 2020. The change in net income of ($1.9) million is primarily attributable to a reduction in operating profit of ($1.2) million, changes in the fair value of warrants of ($1.5) million, decreased income tax expense of $0.2 million between the respective periods, offset by a reduction in deemed dividends on participating warrants of $0.6 million not in the current year period. There were no deemed dividends in the current year period due to the net loss. 10 Six Months Ended March 28, 2021 Compared to the Six Months Ended March 29, 2020 Revenues . In the six months ended March 28, 2021, revenues decreased by $4.1 million or 32.1% from the respective prior period in fiscal year 2020 as set forth in the table below: Six months ended (Thousands) Product Line March 28, 2021 March 29, 2020 Variance % Chg Periscopes $ 3,567 $ 5,327 $ (1,760 ) (33.0 ) Sighting Systems 1,183 375 808 215.5 Howitzers 200 - 200 - Other 883 2,364 (1,481 ) (62.6 ) Optical Systems - Richardson 5,833 8,066 (2,233 ) (27.7 ) Applied Optics Center - Dallas 2,884 4,767 (1,883 ) (39.5 ) Total Revenue $ 8,717 $ 12,833 $ (4,116 ) (32.1 ) Revenue on our periscope line decreased by $1.8 million or 33.0% on lower customer demand during the six months ended March 28, 2021 as compared to the six months ended March 29, 2020. Sighting systems revenue for the six months ending March 28, 2021 increased by $0.8 million or 215.5% from revenues in the prior year period on shipments against our DDAN spares and CWSS programs not in the prior year six-month period. The DDAN program completed in the first fiscal quarter, with continued CWSS shipments anticipated through May of 2021. Other product revenue decreased by $1.5 million, or 62.6% during the six months ending March 28, 2021 as compared to the prior year period due to lower contract demand on MRS collimators and cell assemblies. Applied Optics Center revenue decreased $1.9 million or 39.5% during the six months ended March 28, 2021 as compared to the six months ended March 29, 2020. The lower revenue was primarily driven by lower customer orders across coated filter and optical assembly lines. During the first half of fiscal year 2021, we have seen an increase in customer proposal requests and have booked an additional $5.2 million in new orders for optical assemblies and coated filters, including $0.6 million in new business from a new customer for delivery in 2021 and beyond. Gross Margin . The gross margin during the six-month period ending March 28, 2021 was 13.9% of revenue as compared to a gross margin of 24.0% of revenue for the period ending March 29, 2020. The decreased margin during the six-month period is primarily attributable lower revenue across both segments and unfavorable manufacturing overhead adjustments on reduced production volume. Cost of sales decreased to $7.5 million for the current period as compared to the prior year period of $9.7 million on lower period revenue. G&A Expenses . During the six months ended March 28, 2021 and March 29, 2020, we recorded operating expenses of $1.5 million and $1.6 million, respectively. Operating expenses decreased by 2.5% between the respective periods primarily due to lower spending in office supplies, travel and trade shows. Operating (Loss) Income . During the six months ended March 28, 2021, we recorded an operating loss of ($0.3) million, as compared to operating income of $1.5 million during the six months ended March 29, 2020. The ($1.8) million decrease in operating income in the current year period over the prior year period is primarily due to decreased revenue and gross margin, offset by slightly lower general and administrative spending in the current year as compared to the prior year period. 11 Other (Expense) Income. During the six months ended March 28, 2021, we recognized a $0.9 million gain on change in the fair value of warrants as compared to a $0.1 million gain in six months ending March 29, 2020. The $0.8 million change in the fair value of warrants is primarily attributable to changes in the common stock volatility, US treasury rates, stock price and remaining warrant term from the prior period end. Additional information related to the change in valuation is discussed under Item 1, “Consolidated Financial Statements, Note 6 – Warrant Liability”. Net Income applicable to common shareholders . During the six months ended March 28, 2021, we recorded a net income applicable to common shareholders of $0.3 million as compared to a net income applicable to common shareholders of $0.8 million during the six months ended March 29, 2020. The reduction in net income of ($0.5) million is primarily attributable to a reduction in operating profit of ($1.8) million, changes in the fair value of warrants of $0.8 million, decreased income tax expense of $0.3 million between the respective periods, offset by a reduction in deemed dividends on participating warrants of $0.2 million not in the current year period. Liquidity and Capital Resources Optex Systems Holdings adopted the provisions of ASC Topic 842 “Leases” as of the fiscal year beginning on September 30, 2019. Optex Systems Holdings has two significant operating facilities leases and one equipment lease which extends beyond twelve months and fall under the guidance of ASC Topic 842. Adoption of ASC Topic 842 resulted in the balance sheet recognition of a right-of-use asset of $1.8 million and corresponding operating lease liabilities of approximately ($1.9) million as of September 30, 2019, the beginning of the prior fiscal year, representing the present value of future lease payments for the term of the equipment lease and both segment facility leases and which assumes the exercise of a five-year renewal option at the Applied Optics Center as of November 1, 2021. On January 11, 2021 the Company executed amendments for each of the leased facilities extending the terms for eighty-six (86) months, commencing at the end of the current lease agreements. The Richardson lease amendment commences on April 1, 2021 for an eighty-six (86) month term ending on May 31, 2028. The Dallas lease amendment commences on November 1, 2021 for an eighty-six (86) month term ending on December 31, 2028. Each of the leases include two full months of rent abatement at the beginning of the commencement term. Execution of the new lease amendments for the Dallas and Richardson facilities on January 11, 2021 resulted in the balance sheet recognition of a right-of-use asset of $3.7 million and corresponding operating lease liabilities of approximately ($3.7) million during the six months ended March 28, 2021. As of March 28, 2021, the Company had working capital of $11.5 million, as compared to $11.7 million as of September 27, 2020. During the six months ended March 28, 2021, the Company generated an operating loss of ($0.3) million as compared to operating income of $1.5 million for the six-month period ending March 28, 2021. The Company’s adjusted EBITDA decreased by $1.8 million during the six months ended March 28, 2021 from $1.7 million to ($0.1) million. Backlog as of March 28, 2021 has decreased by $0.3 million or (1.8%) to $16.0 million as compared to a backlog of $16.3 million as of September 27, 2020. We believe the COVID-19 pandemic is a driving factor in lower contract awards and reduced backlog, as many customers and agencies adapt to remote work arrangements, limited travel and slower Defense Contract Management Agency (DCMA) and Defense Contract Audit Agency (DCAA) responses to solicitations, price audits and contract awards. In addition, the most recent U.S. Department of Defense Budget Request reflects a shift in military priorities away from ground system vehicles to other military agencies. At present, the Company has several large outstanding proposals pending and is anticipating additional contract awards over the coming months. Optex Systems Holdings, Inc. is defined as essential critical infrastructure as a defense contractor under the guidance of the federal, state and local authorities for both our Optex Systems (Richardson, TX), and Applied Optics Center (Dallas, TX) operating segments. As such, the Company continued to remain open during the COVID-19 shelter in place orders and closures. The Company remains fully operational with a complete workforce while practicing the CDC guidelines and required Dallas County mandates which require keeping a 6’ distance between employees, face coverings, and daily employee health screening. To date, we have experienced very limited workforce disruption associated with COVID-19 illnesses, COVID-19 quarantine or childcare leave related issues. 12 We have reached out to our customers, suppliers and service providers regarding any potential impacts to operating conditions due to COVID-19 and we will continue to monitor any changes to our operations on an ongoing basis during the crisis. As a large majority of our customers and suppliers are engaged in significant defense manufacturing, they also remain open and operational during the pandemic. The Company has experienced several short- term delays in the delivery of some production supplies and materials, in addition to a few customer delivery schedule revisions, however, the impact to our operations to date have been minimal, and we have taken additional steps to mitigate potential key supplier risks. In addition, we have experienced some minor disruptions in activities related to travel restrictions, conferences and trade show cancellations. Our customers continue to pay outstanding accounts receivable balances to terms and we continue to pay to our supplier terms without interruption during the crisis. During the previous twelve months, we have experienced a significant reduction in new orders and ending customer backlog across all but one of our product lines. We attribute the lower orders to a combination of factors including a COVID-19 driven slow-down of contract awards for both U.S. military sales and foreign military sales (FMS), combined with some shifting in defense spending budget allocations in US military sales and FMS away from Army ground system vehicles toward other military agency applications. We experienced a 32% reduction in revenue volume during the first six months of fiscal year 2021, as compared to the first six months of fiscal year 2020. Due to the significant level of uncertainty surrounding the pandemic and its impact to our customers and the defense supply chain, we are unable to ascertain the impact further delays in contract awards and customer orders may have on our total fiscal year 2021 revenues but are anticipating an annual reduction in the range of 26-32% compared to fiscal year 2020 revenues. We have experienced a recent increase in proposal requests, and anticipate an increase in orders over the next six to twelve months, however the timing and nature of new orders in the near term cannot be determined. Any continued delays in customer orders over the next three months could further impact our total fiscal year 2021 revenue and profitability during the second half. We have implemented several cost-saving initiatives during the first half, including reductions in force and employee compensation combined with decreases in other discretionary spending. We are reviewing additional cost reductions during the next sixty to ninety days as required to further minimize the impact of any sustained delays in customer orders beyond the first six months of fiscal year 2021. We have not received and are not presently seeking any financial assistance under the Coronavirus Aid, Relief, and Economic Security (CARES) Act or other COVID-19 related federal or state programs beyond the Families First Coronavirus Response Act (FFCRA) tax credit which is available to cover paid sick or family leave for our effected employees. Our current backlog and working capital position remain healthy with additional unused working capital available. On April 16, 2020, we executed a two-year $2.25 million revolving credit facility with BBVA USA, replacing the existing $2.25 million AvidBank line of credit which expired on April 21, 2020. Optex intends to use this revolving credit facility to support working capital for the Company’s continuing operations and growth needs during the next twelve months. While we anticipate the possibility of some additional unforeseen operational impacts during the next six months related to the pandemic, we believe we are in a strong position to minimize any significant adverse impact to working capital for the current fiscal year ending October 3, 2021. The Company has historically funded its operations through working capital, convertible notes, stock offerings and bank debt. The Company’s ability to generate positive cash flows depends on a variety of factors, including the continued development and successful marketing of the Company’s products. At March 28, 2021, the Company had approximately $3.9 million in cash and an outstanding payable balance of $0.4 million against our working line of credit. The line of credit allowed for borrowing up to a maximum of $2.25 million. As of March 28, 2021, our outstanding accounts receivable was $2.0 million. The Company anticipates an operating loss for the fiscal 2021 year, but is projecting a positive cash flow from operating activities through the second half of 2021. Successful transition to attaining and maintaining profitable operations is dependent upon maintaining a level of revenue adequate to support the Company’s cost structure. Management intends to manage operations commensurate with its level of working capital and facilities line of credit during the next twelve months; however, uneven revenue levels driven by changes in customer delivery demands, first article inspection requirements, COVID-19 or other program delays combined with increasing inventory and production costs required to support the backlog could create a working capital shortfall. In the event the Company does not successfully implement its ultimate business plan, certain assets may not be recoverable. As of September 27, 2020, and March 28, 2021, there are no outstanding declared and unpaid dividends. On June 8, 2020 the Company announced authorization for a $1 million stock repurchase program. The shares authorized to be repurchased under the new repurchase program may be purchased from time to time at prevailing market prices, through open market or in negotiated transactions, depending upon market conditions and subject to Rule 10b-18 as promulgated by the SEC. As of March 28, 2021, the Company has repurchased 480,667 common shares at a cost of $930 thousand. The shares are held in Treasury Stock at cost. 13 Cash Flows for the Period from September 27, 2020 through March 28, 2021 Cash and Cash Equivalents: As of March 28, 2021, and September 27, 2020, we had cash and cash equivalents of $3.9 and $4.7 million, representing a net decrease of $0.8 million. Net Cash Provided by Operating Activities . Net cash provided by operating activities during the six months from September 27, 2020 to March 28, 2021 totaled $0.1 million. The primary sources of cash during the period relate to collections of accounts receivable of $0.9 million, offset by increased inventory of ($0.2) million and payments against accounts payable and accrued expenses of ($0.6) million. Net Cash Used in Investing Activities . In the six months ended March 28, 2021, cash used in investing activities was $0.1 million for purchases of equipment. Net Cash Used in Financing Activities . Net cash used in financing activities was $0.8 million during the six months ended March 28, 2021 and relate to the repurchases of common stock of $0.7 million as part of our stock repurchase plan and payments for taxes for net settled restricted stock units. Critical Policies and Accounting Pronouncements Our significant accounting policies are fundamental to understanding our results of operations and financial condition. Some accounting policies require that we use estimates and assumptions that may affect the value of our assets or liabilities and financial results. These policies are described in “Critical Policies and Accounting Pronouncements” and Note 2 (Accounting Policies) to consolidated financial statements in our Annual Report on Form 10-K for the year ended September 27, 2020. Cautionary Factors That May Affect Future Results This Quarterly Report on Form 10-Q and other written reports and oral statements made from time to time by Optex Systems Holdings may contain so-called “forward-looking statements,” all of which are subject to risks and uncertainties. You can identify these forward-looking statements by their use of words such as “expects,” “plans,” “will,” “estimates,” “forecasts,” “projects” and other words of similar meaning. You can identify them by the fact that they do not relate strictly to historical or current facts. These statements are likely to address Optex Systems Holdings’ growth strategy, financial results and product and development programs. You must carefully consider any such statement and should understand that many factors could cause actual results to differ from Optex Systems Holdings’ forward-looking statements. These factors include inaccurate assumptions and a broad variety of other risks and uncertainties, including some that are known and some that are not. No forward-looking statement can be guaranteed and actual future results may vary materially. Optex Systems Holdings does not assume the obligation to update any forward-looking statement. You should carefully evaluate such statements in light of factors described in this Form 10-Q. In various filings Optex Systems Holdings has identified important factors that could cause actual results to differ from expected or historic results. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties. Item 4. Controls and Procedures Evaluation of Disclosure Controls and Procedures As of the end of the period covered by our Quarterly Report on Form 10-Q for the quarter ended March 28, 2021, management performed, with the participation of our Principal Executive Officer and Principal Financial Officer, an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Our disclosure controls and procedures are designed to ensure that information required to be disclosed in the report we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s forms, and that such information is accumulated and communicated to our management including our Principal Executive Officer and our Principal Financial Officer, to allow timely decisions regarding required disclosures. Based upon the evaluation described above, our Principal Executive Officer and our Principal Financial Officer concluded that, as of March 28, 2021, our disclosure controls and procedures were effective. 14 Changes in Internal Control Over Financial Reporting During the six months ended March 28, 2021, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. The Company has not experienced any significant disruptions in controls over financial reporting as a result of COVID-19. PART II - OTHER INFORMATION Item 1. Legal Proceedings We are not aware of any material litigation pending or threatened against us. Item 1A . Risk Factors There have been no material changes in risk factors since the risk factors set forth in the Form 10-K filed for the year ended September 27, 2020. Item 4. Mine Safety Disclosures Not applicable . Item 6. Exhibits Exhibit No. Description 31.1 and 31.2 Certifications pursuant to Section 302 of Sarbanes Oxley Act of 2002 32.1 and 32.2 Certifications pursuant to Section 906 of Sarbanes Oxley Act of 2002 EX-101.INS XBRL Instance Document EX-101.SCH XBRL Taxonomy Extension Schema Document EX-101.CAL XBRL Taxonomy Extension Calculation Linkbase Document EX-101.DEF XBRL Taxonomy Extension Definition Linkbase Document EX-101.LAB XBRL Taxonomy Extension Label Linkbase Document EX-101.PRE XBRL Taxonomy Extension Presentation Linkbase Document 15 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. OPTEX SYSTEMS HOLDINGS, INC. Date: May 7, 2021 By: /s/ Danny Schoening Danny Schoening Principal Executive Officer OPTEX SYSTEMS HOLDINGS, INC. Date: May 7, 2021 By: /s/ Karen Hawkins Karen Hawkins Principal Financial Officer and Principal Accounting Officer 16